| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mannkind Corporation (MNKD) has 17 insiders with recent SEC Form 4 filings, including 9 buys and 1 sell. MNKD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.03M | $3.99M | - | |
| CEO | 796.0K | $3.10M | - | |
| VP | 460.8K | $1.79M | - | |
| VP | 349.8K | $1.36M | - | |
| Other | 344.2K | $1.34M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2017 | Kresa Kent | Director | Buy | 166,600 | $6.00 | $999,600.00 | +234.7% | |
| Aug 10, 2017 | Urbanski Raymond W. | Corp VP, CMO | Sell | 296 | $1.15 | $340.40 | -9.2% | |
| Jun 30, 2017 | Alinaya Rosabel Realica | SVP, Investor Relations | Buy | 2,000 | $1.23 | $2,460.00 | +7.1% | |
| Jun 30, 2017 | Pfeffer Matthew J | Director | Buy | 2,000 | $1.23 | $2,460.00 | +2.5% | |
| Jan 3, 2017 | Pfeffer Matthew J | CEO, CFO, Director | Buy | 4,540 | $0.54 | $2,451.60 | +1.1% | |
| Jan 3, 2017 | Alinaya Rosabel Realica | SVP, Prin Acctg Officer | Buy | 9,043 | $0.54 | $4,883.22 | +6.9% | |
| Aug 26, 2016 | Castagna Michael55 | Chief Commercial Officer | Buy | 17,500 | $0.78 | $13,650.00 | +9.0% | |
| Aug 24, 2016 | Castagna Michael55 | Chief Commercial Officer | Buy | 15,000 | $0.87 | $13,050.00 | +8.3% | |
| Aug 23, 2016 | Castagna Michael55 | Chief Commercial Officer | Buy | 25,000 | $0.94 | $23,467.50 | +16.1% | |
| Aug 15, 2016 | Pfeffer Matthew J | CEO, CFO, Director | Buy | 25,000 | $0.99 | $24,650.00 | +6.7% |